We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Developing a SARS-CoV-2 vaccine presents numerous and unprecedented challenges; prominent among them are greatly accelerated timelines. Ordinarily for a new drug product, there is sufficient time for selection/evaluation of the vial/stopper packaging system – one that guarantees quality and safety from manufacture through delivery. This is not the case for a SARS-CoV-2 vaccine where the primary packaging system must be chosen quickly, creating a higher risk.
This risk can be mitigated by selecting the best performing stoppers, namely stoppers with FluroTec® film. This is discussed in a new report by West scientists: Elastomer Stoppers with FluroTec Film: The Right Choice for SARS-CoV-2 Vaccines.
Employing the chemical properties of fluoropolymers, stoppers with FluroTec film: (1) reduce migration of leachables, (2) reduce interaction with drug product, and (3) enable excellent container closure integrity at low temperatures. Globally available and market accepted, based upon West analyses, they are FDA/EMA approved for over 125 drugs, including three vaccines and 30 novel drugs. Available in multiple formats and sizes (serum/lyophilization, 13/20mm), they can accommodate a variety of vaccine formats (currently six are in development). Taken altogether, stoppers with FluroTec film are clearly the best choice, and enable the lowest risk, for SARS-CoV-2 vaccine package systems.
For more information, contact an account manager or Technical Customer Service (TCS) representative.
FluroTec® is a registered trademark of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.
FluroTec® technology is licensed from Daikyo Seiko, Ltd.
West is pleased to welcome guest blogger John Ragland, Jr., Chief Product Officer, <a href="https://healthprize.com/"><span style="color: #6d6d6d; text-decoration: underline;">HealthPrize Technologies</span></a>. This is the third installment in a series on the West/HealthPrize collaboration.
<span style="color: #333333;">Technology is becoming a common component to any drug delivery mechanism. With West’s ongoing partnership with connected health expert, <a href="/sitecore/service/notfound.aspx?item=web%3a%7b91ADE0E1-ABB4-4B9C-BC44-C84AF2B9D310%7d%40en"><span style="color: #0000ff; text-decoration: underline;">HealthPrize</span></a>, a new course to improve patient outcomes has been charted. By connecting West <a href="/products/self-injection-platforms"><span style="color: #0000ff; text-decoration: underline;">drug delivery systems</span></a> with the training, education and rewards from the HealthPrize model, we are addressing some of the most fundamental challenges surrounding adherence.</span>
On August 16, 2017, West’s Women Investing and Networking (WIN) group and the Healthcare Businesswomen’s Association (HBA) held a “Speak to be Heard” event, featuring guest speaker, Gerrie Dresser. Ms. Dresser, CEO and Founder of Unique Impact, taught attendees key strategies to speak up, be assertive and be likeable.
We are happy to announce that West received the 2015 India Pharma Award for Outstanding Primary Packaging for Injectables for our high-quality NovaPure® components. The award was presented to West during the CPhI India Pre-Connect Congress.
<p>West is proud to announce our inaugural Corporate Responsibility (CR) Report that is now live on the West website. We strive to uphold and surpass industry standards for CR around the globe, and this report gives us the opportunity to outline how West’s initiatives have shaped our culture and are vital to the success of our business. </p><p>West’s 2016 Corporate Responsibility Report highlights five key areas that we believe are most important to our business and stakeholders:</p><ul><li>Compliance and Ethics</li><li>Philanthropy</li><li>Diversity</li><li>Health and Safety</li><li>Environmental Sustainability</li></ul><p>Below is Part One of a blog series, highlighting our commitment to Compliance and Ethics.</p>
English
Chinese
